| NcRNA | Expression | Effect on autophagy | Main result (s) | Model | Refs |
---|---|---|---|---|---|---|
MiRNAs | MiR-214 | Up-regulated | Inhibited | In CRC cells, IR-induced autophagy increased radioresistance Through the inhibition of autophagy, miR-214 significantly increased the radiosensitivity of CRC | In vitro In vivo | [174] |
MiR-31 | Down-regulated | Activated | In CAF, miR-31 could significantly reduce the induction of autophagy Up-regulation of miR-31 increased apoptosis in CRC cells but didn`t have any effects on the cell cycle | In vitro | [172] | |
MiR-210 | Down-regulated | Inhibited | By upregulating Bcl-2 expression in hypoxic condition, miR-210 inhibition increased radiosensitivity and decreased autophagy | In vitro | [177] | |
MiR-338-5p | Up-regulated | Inhibited | MiR-338-5p controlled the EMT together with the suppression of autophagy, and increased CRC invasion by reducing PIK3C3 | In vitro In vivo | [170] | |
MiR-125b | Up-regulated | Activated | The decreased apoptosis and increased autophagy in the cancer cells overexpressing miR-125b made them less sensitive to 5-FU than those expressing pre-miR-NC | In vitro In vivo | [181] | |
MiR-22 | Up-regulated | Inhibited | By preventing autophagy and increasing apoptosis, miR-22 increased the susceptibility of CRC cells to treatment with 5-FU | In vitro In vivo | [182] | |
MiR-135b-5p | Up-regulated | Activated | Through the MUL1/ULK1 signaling pathway, miR-135b-5p overexpression in CRC induced protective autophagy and increased oxaliplatin resistance | In vivo | [315] | |
MiR-34a/b/c | Down-regulated | Activated | Concurrent deletion of miR-34a and miR-34b/c increased invasion, migration, and EMT, decreased susceptibility to chemotherapeutics, increased stress-induced autophagic flux, and lowered apoptosis | In vitro | [316] | |
MiR-483 | Up-regulated | Inhibited | MiR-483 endogenously adjusted the expression of EI24 and the growth of CRC cells | In vitro | [317] | |
MiR-31-5p | Down-regulated | Activated | By mediating autophagy, miR-31-5p knockdown significantly reduced the malignant behaviors of CRCÂ cells | In vivo | [318] | |
MiR-21 | Down-regulated | Activated | Tangerine recovered the expression of the target gene PTEN, decreased Akt activation, promoted autophagy, and blocked miR-21 production in cells that had been exposed to 5-FU | In vitro In vivo | [319] | |
MiR-145 | Down-regulated | Activated | Through the HDAC4/p53 axis, ATF4-mediated miR-145 suppression enhanced CRC cell autophagy and increased their resistance to 5-FU | In vivo | [320] | |
LncRNAs | TUG1 | Up-regulated | Activated | TUG1 enhanced CRC cells' resistance to cisplatin by stimulating autophagy, while IGF2BP2 increased TUG1 expression in CRC cells | In vitro In vivo | [321] |
SNHG8 | Up-regulated | Activated | In CRC cells, SNHG8 increased the expression of ATG7 to induce autophagy | In vivo | [186] | |
UCA1 | Down-regulated | Inhibited | By blocking miR-185-5p, UCA1 increased autophagy and SW620 cell proliferation whereas promoting tumor survival by activating the WISP2/β-catenin pathway | In vitro In vivo | [322] | |
CPS1-IT1 | Up-regulated | Activated | By preventing hypoxia-induced autophagy and inactivating HIF-1α in CRC, LncRNA CPS1-IT inhibited metastasis and EMT | In vitro In vivo | [323] | |
SLCO4A1-AS1 | Up-regulated | Activated | SLCO4A1-AS1 substantially increased autophagy and CRC cell proliferation in CRC tissues and served as the miR-508-3p sponge for PARD3 upregulation | In vivo | [324] | |
SNHG6 | Up-regulated | Activated | SNHG6 increased chemoresistance by sponging miR-26a-5p, which led to ULK1-induced autophagy in CRC cells | In vivo | [325] | |
NEAT1 | Down-regulated | Inhibited | LncRNA NEAT1 induced autophagy and targeted miR-34a to increase 5-FU chemoresistance in CRC | In vitro | [326] | |
LINC01871 | Up-regulated | Activated | LncRNA NEAT1 induced autophagy and targeted miR-34a to increase 5-FU chemoresistance in CRC | In vivo | [327] | |
linc-POU3F3 | Up-regulated | Inhibited | Linc-POU3F3 reduced apoptosis while promoting proliferation and metastasis | In vitro | [328] | |
RP4 | Up-regulated | Activated | LncRNA RP4 inhibited colorectal tumorigenesis and triggered autophagy-mediated cell death | In vitro | [329] | |
SP100-AS1 | Down-regulated | Inhibited | Silencing SP100-AS1 counteracted the autophagy that radiation caused in HCT116 cells | In vitro In vivo | [187] | |
Lnc-FAL1 | Up-regulated | Inhibited | In CRC cells, Oxaliplatin-induced autophagy was suggestively reduced by the overexpression of Lnc-FAL1 | In vitro In vivo | [330] | |
LncRNA-TINCR | Down-regulated | Activated | Cell migration, invasion, and proliferation were all dramatically decreased by lncRNA TINCR knockdown, whereas apoptosis and autophagy were both significantly elevated | In vitro | [331] | |
CircRNAs | CircCUL2 | Up-regulated | Activated | Upregulation of circCUL2 targeted the miR-208a-3p/PPP6C signal pathway and suppressed cancer development | In vivo | [98] |
CircUBAP2 | Up-regulated | Activated | A new circUBAP2/miR-582-5p/FOXO1 axis functioned as an oncogene, offering a prospective biomarker and therapeutic target for the therapy of CRC | In vitro In vivo | [195] | |
CircATG4B | Up-regulated | Activated | Through the promotion of autophagy, CircATG4B caused oxaliplatin resistance | In vitro In vivo | [198] | |
CircHIPK3 | Down-regulated | Activated | CircHIPK3 downregulation caused autophagy, which made the resistant CRC cells more susceptible to oxaliplatin by increasing the ratio of LC3B-II to LC3B-I, beclin1 expression, and decreasing p62 expression | In vitro In vivo | [332] | |
CircCCDC66 | Down-regulated | Inhibited | CircCCD66 was increased in CRC cells exposed to hypoxia, which stimulated the development and carcinogenesis of CRC. CircCCD66 inhibition, however, inhibited the malignant behaviors that hypoxia-induced in CRC cells | In vitro In vivo | [333] | |
CircHADHA | Up-regulated | Activated | CircHADHA stimulated autophagy in colon epithelial and cancer cells by controlling ATG13 via miR-361. Through the induction of cell autophagy in CRC cells, CircHADHA reduced tumor development | In vivo | [334] |